Subsequently, Mollie et al. found that some of the cell populations isolated from a BRCA1-deficient mouse mammary tumor were composed of a low percentage of CD24−/CD44+ cells and harbored 2–5.9% CD133+ cells. The gene discussed is CD44; the disease is breast cancer.